S Kahlert Selected Research

S Kahlert Research Topics

Disease

17	Breast Neoplasms (Breast Cancer) 11/2015 - 01/2000
7	Neoplasms (Cancer) 04/2006 - 03/2000
2	Chills 11/2005 - 07/2005
2	Fever (Fevers) 11/2005 - 07/2005
1	Inflammation (Inflammations) 02/2018
1	Necrosis 02/2018
1	Inflammatory Breast Neoplasms 08/2012
1	Brain Neoplasms (Brain Tumor) 04/2006
1	Neoplasm Metastasis (Metastasis) 04/2006
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 11/2005
1	Ischemic Stroke 01/2004
1	Ischemia 01/2004
1	Stomach Neoplasms (Stomach Cancer) 08/2001
1	Hyperglycemia 01/2001
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2001
1	Cardiotoxicity 09/2000
1	Stroke (Strokes) 08/2000
1	Brain Hypoxia (Cerebral Hypoxia) 08/2000
1	Hypoglycemia (Reactive Hypoglycemia) 08/2000
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2000
1	Carcinoma (Carcinomatosis) 03/2000
1	Glioblastoma (Glioblastoma Multiforme) 03/2000

Drug/Important Bio-Agent (IBA)

6	Trastuzumab (Herceptin)FDA Link 04/2006 - 09/2000
4	Epirubicin (Ellence)FDA LinkGeneric 12/2004 - 01/2000
3	AnthracyclinesIBA 08/2012 - 12/2004
3	Gemcitabine FDA Link 05/2006 - 06/2001
3	Proteins (Proteins, Gene)FDA Link 04/2006 - 09/2000
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2004 - 09/2000
3	Adenosine Triphosphate (ATP)IBA 01/2004 - 08/2000
2	taxaneIBA 08/2012 - 05/2006
2	Cisplatin (Platino)FDA LinkGeneric 05/2006 - 12/2005
2	Plasminogen Activator Inhibitor 1IBA 04/2006 - 08/2001
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 04/2006 - 08/2001
2	Tissue ExtractsIBA 04/2006 - 08/2001
2	EnzymesIBA 11/2005 - 07/2005
2	AntibodiesIBA 07/2005 - 08/2001
2	Glucose (Dextrose)FDA LinkGeneric 01/2004 - 01/2001
2	Methotrexate (Mexate)FDA LinkGeneric 05/2001 - 09/2000
2	Fluorouracil (Carac)FDA LinkGeneric 05/2001 - 09/2000
1	LipopolysaccharidesIBA 02/2018
1	KynurenineIBA 02/2018
1	deoxynivalenolIBA 02/2018
1	Tryptophan (L-Tryptophan)FDA Link 02/2018
1	ParaffinIBA 11/2008
1	Estrogen ReceptorsIBA 11/2008
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2008
1	Plasminogen Activators (Plasminogen Activator)IBA 04/2006
1	SurvivinIBA 04/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2006
1	Bispecific AntibodiesIBA 07/2005
1	ErbB-2 ReceptorIBA 06/2005
1	Monoclonal AntibodiesIBA 06/2005
1	Oxygen (Dioxygen)IBA 01/2004
1	Plasminogen InactivatorsIBA 08/2001
1	Peptide Hydrolases (Proteases)FDA Link 08/2001
1	Complementary DNA (cDNA)IBA 08/2001
1	Vinorelbine (Navelbine)FDA LinkGeneric 06/2001
1	Carboplatin (JM8)FDA LinkGeneric 06/2001
1	Drug CombinationsIBA 06/2001
1	Pharmaceutical PreparationsIBA 06/2001
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2001
1	Proteoglycans (Proteoglycan)IBA 01/2001
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2001
1	AgrinIBA 01/2001
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2001
1	N 30IBA 03/2000

Therapy/Procedure

8	Therapeutics 06/2005 - 03/2000
6	Drug Therapy (Chemotherapy) 08/2012 - 01/2000
2	Neoadjuvant Therapy 08/2012 - 04/2004
2	Immunotherapy 11/2005 - 07/2005
1	Segmental Mastectomy (Lumpectomy) 11/2015
1	Adjuvant Radiotherapy 11/2015
1	Combined Modality Therapy 11/2005
1	Stem Cell Transplantation 07/2005
1	Palliative Care (Palliative Therapy) 06/2004
1	Cesarean Section (Caesarean Section) 06/2004